The results from the present study will expand our knowledge pertaining to the critical role of the Keap1/Nrf2 signaling pathway in T1DM, which might provide a useful pharmacological strategy for the clinical prevention and treatment of T1DM based on specifically targeting the Keap1/Nrf2 signaling pathway. This evidence concerns the gene NFE2L2 and type 1 diabetes mellitus.